Clinical Trial Update: Sympathetic Overactivity in Essential Hypertension

View source ↗

Summary

A clinical trial investigating sympathetic overactivity in essential hypertension and related proteinuria has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Proteinuria

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Hypertension, Proteinuria | Status: WITHDRAWN